海港治疗公司 SPTX
$21.50 +$1.11 (+5.44%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $21.50 0.00%
开盘$20.85
昨收$20.39
当日区间$19.77 – $21.75
成交量227.0K
市值$1.15B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$65.81M-256.3% YoY
净利润-$62.60M-315.2% YoY
摊薄每股收益-$1.78-356.3% YoY
自由现金流-$26.14M-67.6% YoY
经营现金流-$26.14M
营收，近4个季度
净利润，近4个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
净资产收益率-31.9%
资产收益率-30.5%
投入资本回报率-33.0%
流动比率18.00
负债/资产比率4.3%
现金及投资$273.31M
总负债$3.41M
净现金（净负债）$269.90M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 净利润 | -$62.60M | -$25.41M | -$74.88M | -$15.08M | -$13.13M |
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $65.81M | $27.54M | $87.29M | $18.47M | $16.19M |
| 基本每股收益 | -$1.78 | -$0.48 | -$1.94 | -$0.39 | -$0.34 |
| 摊薄每股收益 | -$1.78 | -$0.48 | -$1.94 | -$0.39 | -$0.34 |
| 归属普通股股东净利润 | -$62.60M | -$25.41M | -$74.88M | -$15.08M | -$13.13M |
| 归属母公司净利润 | -$62.60M | -$25.41M | -$74.88M | -$15.08M | -$13.13M |
| 持续经营利润 | -$62.60M | -$25.41M | -$74.88M | -$15.08M | -$13.13M |
| 销售及管理费用 | $41.19M | $6.11M | $20.98M | $5.06M | $5.65M |
| -管理费用 | $41.19M | $6.11M | $20.98M | $5.06M | $5.65M |
| 研发费用 | $24.62M | $21.43M | $66.31M | $13.41M | $10.53M |
| 营业利润 | -$65.81M | -$27.54M | -$87.29M | -$18.47M | -$16.19M |
| 非经营性利息收入 | $3.26M | $2.13M | $11.40M | $2.98M | $3.10M |
| 其他收入（支出） | $202,000.00 | $521,000.00 | $1.78M | $551,000.00 | -$9,000.00 |
| 其他非经营性收入（支出） | $202,000.00 | $521,000.00 | $1.78M | $551,000.00 | -$9,000.00 |
| 税费 | $251,000.00 | $519,000.00 | $773,000.00 | $134,000.00 | $31,000.00 |
| 税前利润 | -$62.35M | -$24.89M | -$74.11M | -$14.94M | -$13.09M |
| 非经营性利息净收入（支出） | $3.26M | $2.13M | $11.40M | $2.98M | $3.10M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2024 ANNUAL |
|---|---|---|---|---|
| -累计折旧 | -$1.04M | -$1.02M | -$989,000.00 | -$837,000.00 |
| 投资及预付款 | $153.95M | $30.04M | $17.67M | $0.00 |
| 其他非流动资产 | $454,000.00 | $3.84M | $2.88M | $454,000.00 |
| 负债合计 | $19.08M | $343.29M | $341.55M | $340.63M |
| 流动负债合计 | $15.67M | $14.22M | $12.78M | $11.15M |
| 应付款 | $5.71M | $4.80M | $2.01M | $5.08M |
| -应付账款 | $5.71M | $4.79M | $2.01M | $4.73M |
| -一年内应付关联方款项 | $0.00 | $11,000.00 | $7,000.00 | $351,000.00 |
| 一年内应计费用 | $5.29M | $6.11M | $3.94M | $2.29M |
| 短期债务及融资租赁负债 | $1.61M | $1.60M | $1.64M | $857,000.00 |
| -固定资产原值 | $6.14M | $6.47M | $6.21M | $6.01M |
| 固定资产净值 | $5.10M | $5.45M | $5.23M | $5.17M |
| 非流动资产合计 | $159.51M | $39.33M | $25.78M | $5.63M |
| 总资产 | $441.68M | $227.67M | $249.01M | $315.78M |
| 流动资产合计 | $282.18M | $188.34M | $223.23M | $310.15M |
| 现金及现金等价物与短期投资 | $273.31M | $182.61M | $215.98M | $309.10M |
| -现金及现金等价物 | $64.22M | $52.91M | $46.04M | $309.10M |
| -短期投资 | $209.09M | $129.70M | $169.94M | $0.00 |
| 应收款 | $4.86M | $3.28M | $3.03M | $0.00 |
| -应计应收利息 | $2.72M | $1.38M | $1.73M | $0.00 |
| -应收税款 | $2.14M | $1.89M | $1.30M | $0.00 |
| 预付资产 | $4.01M | $2.46M | $4.22M | $1.05M |
| -一年内到期融资租赁负债 | $1.61M | $1.60M | $1.64M | $857,000.00 |
| -长期融资租赁负债 | $3.41M | $3.74M | $3.44M | $4.15M |
| 可转换优先证券 | $0.00 | $325.33M | $325.33M | $325.33M |
| 股东权益合计 | $422.60M | -$115.62M | -$92.55M | -$24.85M |
| 股东权益 | $422.60M | -$115.62M | -$92.55M | -$24.85M |
| 股本 | $5,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -普通股 | $5,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| 资本公积 | $625.19M | $23.83M | $21.26M | $14.38M |
| 留存收益 | -$202.12M | -$139.52M | -$114.11M | -$39.23M |
| 非流动负债合计 | $3.41M | $329.07M | $328.77M | $329.48M |
| 长期债务及融资租赁负债 | $3.41M | $3.74M | $3.44M | $4.15M |
| 不影响留存收益的损益 | -$475,000.00 | $64,000.00 | $301,000.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 持续经营筹资活动现金流净额 | $240.93M | -$783,000.00 | -$873,000.00 | $0.00 | $0.00 |
| 筹资活动现金流 | $240.93M | -$783,000.00 | -$873,000.00 | $0.00 | $0.00 |
| 投资购置及出售净额 | -$203.50M | $27.85M | -$183.89M | -$1.17M | -$225.50M |
| 固定资产购置及出售净额 | $0.00 | $0.00 | -$356,000.00 | -$269,000.00 | -$54,000.00 |
| 投资活动现金流净额 | -$203.50M | $27.85M | -$184.25M | -$1.44M | -$225.55M |
| -其他流动负债变动 | -$329,000.00 | -$323,000.00 | -$1.04M | -$260,000.00 | -$230,000.00 |
| -其他流动资产变动 | $0.00 | $0.00 | -$1.56M | $0.00 | -$1.19M |
| -应付账款及应计费用变动 | $1.94M | $1.29M | $877,000.00 | $1.93M | -$4.10M |
| -预付资产变动 | -$2.00M | $1.57M | -$6.21M | -$2.84M | -$2.66M |
| 营运资金变动 | -$396,000.00 | $2.53M | -$7.93M | -$1.17M | -$8.18M |
| 折旧、折耗与摊销 | $351,000.00 | $357,000.00 | $1.41M | $354,000.00 | $315,000.00 |
| 期末现金余额 | $64.68M | $53.36M | $46.50M | $47.03M | $63.80M |
| 现金净变动 | $11.29M | $6.90M | -$263.06M | -$16.77M | -$245.76M |
| 持续经营投资活动现金流净额 | -$203.50M | $27.85M | -$184.25M | -$1.44M | -$225.55M |
| 自由现金流 | -$26.14M | -$20.17M | -$78.30M | -$15.59M | -$20.26M |
| 汇率变动影响 | $29,000.00 | -$28,000.00 | $3,000.00 | $0.00 | $0.00 |
| 期初现金余额 | $53.36M | $46.50M | $309.55M | $63.80M | $309.55M |
| 持续经营净利润 | -$62.60M | -$25.41M | -$74.88M | -$15.08M | -$13.13M |
| 持续经营经营活动现金流净额 | -$26.14M | -$20.17M | -$77.94M | -$15.33M | -$20.21M |
| 经营活动现金流 | -$26.14M | -$20.17M | -$77.94M | -$15.33M | -$20.21M |
| 其他筹资费用净额 | – | -$783,000.00 | -$874,000.00 | – | – |
| 股票期权行使所得 | – | – | $1,000.00 | – | – |
| 优先股发行净额 | – | – | $0.00 | – | – |
| 持续经营损益 | – | – | $11,000.00 | – | – |
暂无评论——快来第一个聊聊 SPTX。
登录后参与讨论。